Surgery Partners Inc.

NASDAQ: SGRY · Real-Time Price · USD
22.78
0.28 (1.24%)
At close: Aug 15, 2025, 12:17 PM

Surgery Partners Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
826.2M 776M 864.4M 770.4M 762.1M 717.4M 735.4M 674.1M 667.6M 666.2M 707.1M 620.6M 615.4M 596.2M 610.2M 559.2M 543.3M 512.4M
Cost of Revenue
630.6M 614.1M 630.8M 592.9M 582.9M 562.1M 541.8M 508.3M 513.5M 532.2M 522.8M 489.4M 480.8M 471.4M 463.1M 436.7M 425M 408.9M
Gross Profit
195.6M 161.9M 233.6M 177.5M 179.2M 155.3M 162.5M 165.8M 154.1M 134M 184.3M 131.2M 134.6M 124.8M 147.1M 122.5M 118.3M 103.5M
Operating Income
111.7M 61.9M 127.1M 60.9M 84.8M 76M 101.4M 82.6M 97.6M 72.4M 140.2M 74.1M 76.5M 74.6M 114.8M 63.6M 59.5M 64.3M
Interest Income
n/a n/a n/a n/a n/a n/a n/a 49.8M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
43.8M -300K 74.2M 10.9M 33.3M 28.7M 52.7M 32.8M 49.9M -400K 33.2M 13.4M 19.6M 44.1M 54.7M 9.4M 6.1M 11M
Net Income
-2.5M -37.7M -108.5M -31.7M -15.5M -12.4M -1M 35.9M 18.9M 1.2M 23.3M -25M 15.3M 42.8M -100K -22.9M -26.9M -21M
Selling & General & Admin
36.1M 36M 36M 120.2M 40.3M 33.2M 20.9M 109.2M 31.2M 32M 28.7M 17.9M 26.1M 29.5M 27.2M 25.5M 24.5M 26.8M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
47.8M 64M 70.5M n/a n/a 46.1M 71.3M n/a 25.3M 32.6M 29M 2.4M 25.3M 26.2M 12.2M 500K 17.5M 10.6M
Operating Expenses
83.9M 100M 106.5M 120.2M 94.4M 79.3M 92.2M 109.2M 56.5M 64.6M 57.7M 47.2M 51.4M 55.7M 32M 50.2M 42M 37.4M
Interest Expense
67.9M 62.2M 52.9M 50M 51.5M 47.3M 48.7M 49.8M 47.7M 46.8M 61M 60.7M 56.9M 56.3M 60.1M 54.2M 53.4M 53.3M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
714.5M 714.1M 737.3M 709.5M 677.3M 629M 634M 617.5M 570M 596.8M 580.5M 536.6M 532.2M 527.1M 495.1M 486.9M 467M 446.3M
Income Tax Expense
-1.1M n/a 120.8M 4.5M 4.9M 4.4M 6M -3.1M -7.8M -1.6M 9.9M 7.8M 4.3M 1.3M 11.8M 1.2M -2.7M 200K
Shares Outstanding (Basic)
126.98M 126.6M 126.21M 126.17M 126.13M 125.97M 125.77M 125.75M 125.72M 125.21M 101.89M 88.91M 87.62M 88M 84.52M 80.73M 68.97M 54.77M
Shares Outstanding (Diluted)
126.98M 126.6M 126.21M 126.17M 126.13M 125.97M 125.77M 125.75M 127.37M 125.21M 101.89M 88.91M 88.9M 90.27M 84.52M 80.73M 69.27M 54.77M
EPS (Basic)
-0.02 -0.3 -0.86 -0.25 -0.12 -0.1 -0.01 0.29 0.15 0.01 0.23 -0.28 0.17 0.49 -0.00 -0.28 -0.39 -0.38
EPS (Diluted)
-0.02 -0.3 -0.86 -0.25 -0.12 -0.1 -0.01 0.29 0.15 0.01 0.23 -0.28 0.17 0.47 -0.00 -0.28 -0.39 -0.38
EBITDA
152M 98.2M 161M 111.1M 119.6M 109.7M 132.5M 111.5M 122M 80.1M 169.8M 103.9M 104.5M 127.8M 137.5M 88.8M 84.7M 90M
EBIT
111.7M 61.9M 127.1M 60.9M 84.8M 76M 101.4M 82.6M 97.6M 46.4M 98.1M 74.1M 76.5M 100.4M 114.8M 63.6M 59.5M 64.3M
Depreciation & Amortization
40.3M 36.3M 33.9M 50.2M 34.8M 33.7M 31.1M 28.9M 24.4M 42.7M 37.6M 29.8M 36.5M 36M 31.5M 35.5M 35.4M 35.5M